(Q44818645)

English

The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance

scientific article published in April 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

insulin resistance

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jan J. Štěpán

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Josef V Silha

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Vlasta Justova

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Zdena Lacinova

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Liam J Murphy

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

442-450

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Increased cerebrovascular mortality in patients with hypopituitarism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Clinical aspects of growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

New factors in the regulation of adipose differentiation and metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Increased insulin sensitivity in young, growth hormone deficient children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Growth hormone-deficient adults are insulin-resistant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Growth hormone replacement therapy for adults: into the new millennium.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2004.02000.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2004.02000.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44818645&oldid=2195015372"